TX // Ternium S.A. Ternium S.A. (each representing ten shares USD1.00 par value)
ANR <GO> NYSE RQD COCKPIT → CIK 0001342874 ↗| INSTITUTION / ANALYST | ACTION | RATING | TARGET | PRIOR PT | CALL DATE | PX AT CALL | RET SINCE CALL | 1Y ACCURACY | BS GRADE |
|---|---|---|---|---|---|---|---|---|---|
| Morgan Stanley Institutional Equity Desk | REITERATE | OUTPERFORM | $63.85 | $60.69 | 2025-02-14 | $48.02 | +9.9% | 78% | A |
| Goldman Sachs Global Research Sector Coverage | TARGET REV | STRONG BUY | $66.49 | $62.27 | 2025-02-06 | $49.60 | +6.4% | 74% | A |
| J.P. Morgan Securities US Large Cap | REITERATE | BUY | $60.16 | $58.05 | 2025-01-29 | $50.66 | +4.2% | 67% | B |
| Bernstein Autonomous Forensic Coverage | INITIATE | HOLD | $53.83 | — | 2025-01-17 | $51.71 | +2.0% | 61% | B |
| Barclays Capital Americas Research | DOWNGRADE | UNDERPERFORM | $46.44 | $50.13 | 2025-01-09 | $46.97 | -11.2% | 42% | D |
| UBS Investment Bank Institutional Desk | UPGRADE | BUY | $62.80 | $54.88 | 2024-12-18 | $45.91 | +14.9% | 72% | A |
| Citigroup Global Markets Sector Lead | TARGET REV | HOLD | $51.19 | $53.30 | 2024-12-04 | $49.08 | -4.3% | 48% | C |